RxDoctor Payments Data

Abrahem Kazemi, MD

Dermatology · Centreville, VANPI 1700383585

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $95,038 of the $155,991 with a category attached, or 60.9%. Arcutis Biotherapeutics, Inc. accounts for 68.5% of it on its own, with 30 other manufacturers making up the rest. 2025 is the largest year on record at $119,784, more than ten times the $108 reported in 2019. Among dermatology clinicians in VA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$155,991in general payments, 2019–2025

Across 856 payments — averaging $182.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Arcutis Biotherapeutics, Inc.$107K
  • Galderma Laboratories, L.p.$28K
  • Sanofi$5K
  • AbbVie$3K
  • Johnson & Johnson$2K
  • Lilly USA, LLC$2K
  • plus $10K from 25 others

What the payments were for

  • Consulting fees$95,03861%
  • Speaking & faculty fees$25,70016%
  • Travel & lodging$11,5207%
  • Food & beverage$23,10715%
  • Education$6270%

General payments by program year

19
20
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$155,991 in reported general payments places this provider in the 95th percentile of 396 dermatology providers in Virginia.

See all dermatology providers in Virginia

Medicare billing

Part B allowed, 2024
$51,867
Medicare patients
158
Services billed
566

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Dupixent PenDupilumab34$126,590
Doxycycline Ir-DrDoxycycline Monohydrate25$11,130
Clobetasol Propionate45$2,270
Ivermectin13$2,107
Triamcinolone Acetonide113$1,579
Fluocinolone Acetonide21$1,495
Ketoconazole103$1,310
Tretinoin30$1,267
Imiquimod15$1,155
Clindamycin Phosphate19$984
Metronidazole18$927
CiclopiroxCiclopirox Olamine30$577
Ciclopirox12$539
Hydrocortisone66$337
Ammonium Lactate16$301

Paid to pharmacies, not to this prescriber.

Other dermatology in Centreville

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →